ACORAI
Acorai is building a non-invasive heart failure monitoring platform with direct intracardiac pressure monitoring (ICPM) at its core. Acorai offers accurate and cost-efficient heart failure care using patented technology that leverages a novel combination of sensor technologies and machine learning to enable non-invasive ICPM, the only proven way to improve outcomes in HF patients. The device has been clinically validated, designated FDA Breakthrough Device and will be entering the market in 2025. Acorai is a MedTech company with HQ in Sweden. The company has 20 FTE across 12 countries, with offices in Sweden and the UK.
ACORAI
Industry:
Health Care Medical Device Pharmaceutical
Founded:
2019-08-20
Address:
Helsingborg, Skane Lan, Sweden
Country:
Sweden
Website Url:
http://www.acorai.com
Total Employee:
11+
Status:
Active
Contact:
+46708756781
Email Addresses:
[email protected]
Total Funding:
11.43 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta LetsEncrypt SSL By Default Mobile Non Scaleable Content HSTS Apple Mobile Web App Capable Google Code Prettify October CMS CityNet
Similar Organizations
ARTBIO
ARTBIO is a clinical-stage radiopharmaceutical biotechnology business that is working to create a new class of alpha radioligand medicines.
ARTIDIS
ARTIDIS is committed to innovation and excellence in order to bring the future of health care to people.
flipMD
Connecting physicians to side gigs. Built by physicians for physicians.
InnaMed
Launching HomeLab, a gateway to personalized healthcare in the comfort and privacy of your home. Measure + Analyze + Enhance.
Osciflex
Osciflex system imitates nature’s process to prevent deadly blood clots.
CardioSignal
Cardiac monitoring via smartphone
Pression
Medical device company improving blood flow volume body-wide using smart compression with initial focus on heart failure patients.
Synapse Medicine
Synapse Medicine provides medication decision solutions to deliver enhanced patient-centered insights for care teams.
Terns Pharmaceuticals
Terns Pharmaceuticals is a biopharmaceutical company that focuses on discovering therapies that will improve the global disease burden.
Vasowatch
Deploying decision support technology to improve maternal outcomes and health equity.
Current Advisors List
Current Employees Featured
Founder
Investors List
MedTech Innovator
MedTech Innovator investment in Non Equity Assistance - Acorai
Solardis Health Ventures
Solardis Health Ventures investment in Seed Round - Acorai
CerraCap Ventures
CerraCap Ventures investment in Seed Round - Acorai
Chris Gasteratos
Chris Gasteratos investment in Seed Round - Acorai
KHP Ventures
KHP Ventures investment in Seed Round - Acorai
Carma Fund
Carma Fund investment in Seed Round - Acorai
European Innovation Council
European Innovation Council investment in Grant - Acorai
Springboard Health Angels
Springboard Health Angels investment in Seed Round - Acorai
Golden Angels Investors
Golden Angels Investors investment in Seed Round - Acorai
Capital Q® Ventures Inc.
Capital Q® Ventures Inc. investment in Seed Round - Acorai
Official Site Inspections
http://www.acorai.com Semrush global rank: 2.19 M Semrush visits lastest month: 9.13 K
- Host name: frault1.hostarmada.net
- IP address: 172.105.80.154
- Location: Frankfurt am Main Germany
- Latitude: 50.1188
- Longitude: 8.6843
- Timezone: Europe/Berlin
- Postal: 60313
More informations about "Acorai"
Acorai – non-invasive and scalable intracardiac pressure monitoring
The Acorai Heart Monitor has been designed to offer accurate, personalized, and efficient care for heart failure patients. Absolute The Save Sensor System: First-of-its-kind hardware …See details»
Acorai - Crunchbase Company Profile & Funding
Acorai is building a non-invasive heart failure monitoring platform with direct intracardiac pressure monitoring (ICPM) at its core. Acorai offers accurate and cost-efficient heart failure care using patented technology that leverages a …See details»
Acorai Company Profile 2024: Valuation, Funding & Investors
When was Acorai founded? Acorai was founded in 2019. Where is Acorai headquartered? Acorai is headquartered in Helsingborg, Sweden. What is the size of Acorai? Acorai has 26 total …See details»
Our Team - Acorai
Meet The Team Accorai has built a multi-disciplinary team with demonstrated experience across medical devices, with experience from large device manufacturers and startups. Meet Advisory Board Acorai has built a global …See details»
Our Team – Acorai
Acorai has built a global advisory board of medical device executives, world-leading expert physicians, and thought leaders across healthcare with deep understanding of heart failure …See details»
Heart Failure start-up, Acorai, closes oversubscribed …
Jan 23, 2024 HELSINGBORG, Sweden, Jan. 22, 2024 /PRNewswire/ – Today, Acorai, a start-up medical device manufacturer from Sweden, has announced closing an oversubscribed series seed equity round. Acorai secured more …See details»
Acorai - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Acorai . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... Acorai has 2 board members and advisors, …See details»
Heart Failure start-up, Acorai, closes oversubscribed $4m funding …
Jan 16, 2024 Acorai secured more than $4.5m in funding to finance its clinical studies and move towards regulatory approval, which comes off the back of €2.3m in non-dilutive grant and …See details»
Heart Failure start-up, Acorai, closes oversubscribed $4m funding …
HELSINGBORG, Sweden, Jan. 22, 2024 /PRNewswire/ – Today, Acorai, a start-up medical device manufacturer from Sweden, has announced closing an oversubscribed series seed …See details»
Mission, Vision & Core Values of Acorai – CBM
The Acorai organization is guided by a clear set of principles that shape its direction and operations: the Mission, Vision, and Core Values. Our Mission is to empower individuals and …See details»
Partnerships and Progress: Acorai’s Journey to Better Heart Health
Aug 23, 2024 Acorai's technology may be incorporated into mobile clinics and community health programs, providing vital heart failure diagnoses to patients who might otherwise go untreated. …See details»
CerraCap Ventures Invests in Acorai, Paving the Way for …
Jan 19, 2024 Acorai's Monitoring system was designated a breakthrough device by the FDA in 2023 and is built upon the patented SAVE Sensor System, a proprietary, non-invasive …See details»
Heart Failure start-up, Acorai, embarks on the next vital stage …
HELSINGBORG, Sweden, Aug. 16, 2023 /PRNewswire/ – Today, Acorai, a start-up medical device manufacturer from Sweden, has announced the initiation of a global clinical trial with …See details»
Heart Failure start-up, Acorai, wins US and UK healthcare support
HELSINGBORG, Sweden, Nov. 1, 2022 /PRNewswire/ -- Acorai, a Swedish-based medical device start-up, announces endorsements from two major healthcare players as they prepare …See details»
Heart Failure start-up, Acorai, embarks on the next vital stage …
Aug 16, 2023 A significant milestone in the development of Acorai. The 1200-patient Acorai MLG study will run in two phases, with the first phase concluding after 920 patients, and will be …See details»
Product - Acorai
Product Acorai generates data to aid in heart failure management. Our mission is to empower healthcare professionals with the tools they need to deliver the highest quality care to their …See details»
Heart Failure start-up, Acorai, embarks on the next vital stage …
HELSINGBORG, Sweden, Aug. 16, 2023 /PRNewswire/ – Today, Acorai, a start-up medical device manufacturer from Sweden, has announced the initiation of a global clinical trial with …See details»
Heart failure monitoring startup Acorai turns heads with …
Jan 30, 2024 Medical device startup Acorai is pairing proprietary sensing hardware and machine learning software with the goal of putting a non-invasive heart pressure monitoring tool in the …See details»
Acorai receives Breakthrough Device Designation for their non …
Aug 12, 2023 HELSINGBORG, Sweden, Aug. 10, 2023 /PRNewswire/ — Acorai, a start-up medical device manufacturer from Sweden, today announces that the U.S. Food and Drug …See details»